Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

4,646 total articles

Wayfair CEO Sells $8.4 Million in Stock Amid Mixed Analyst Views

Wayfair CEO Sells $8.4 Million in Stock Amid Mixed Analyst Views

Wayfair Chief Executive Niraj Shah disposed of $8.4 million in Class A shares across transactions on March 23 and 24, 2026, under a pre-established 10b5-1 trading plan. The sales occurred at prices between $75.45 and $78.44. The company has a $10.34 billion market valuation and recent corporate and analyst developments show a range of perspectives …

CCC Intelligent Solutions CAO Sells About $36,000 in Stock as Company Faces Recent Price Weakness

CCC Intelligent Solutions CAO Sells About $36,000 in Stock as Company Faces Recent Price Weakness

CCC Intelligent Solutions Holdings Inc.'s Chief Accounting Officer, Rodney Christo, sold 5,847 shares on March 24 under a pre-arranged Rule 10b5-1 plan for roughly $36,075. The stock is trading below recent levels, and the company has seen board and product leadership appointments alongside new analyst coverage and differing price targets for peer …

Better Home & Finance CEO Increases Stake with $66,298 Purchase

Better Home & Finance CEO Increases Stake with $66,298 Purchase

Better Home & Finance Holding Co Chief Executive Officer Vishal Garg bought 2,217 shares of Class A common stock on March 25, 2026, at a weighted average price of $29.9045 for a total of $66,298. The transaction leaves Garg with 54,877 directly held shares. The purchase comes amid the company’s reported Q4 2025 revenue growth, a shift to an AI-nati…

Flowco Holdings Insider Move: Director Sells $165M in Class A Shares, Also Records Conversion-Based Acquisition

Flowco Holdings Insider Move: Director Sells $165M in Class A Shares, Also Records Conversion-Based Acquisition

Jonathan B. Fairbanks, a director and 10% owner of Flowco Holdings Inc (EXCHANGE:FLOC), indirectly sold 7,904,090 shares of Class A common stock on March 23, 2026, at $21.175 per share for a total of $165,165,000. On the same date he reported an indirect acquisition of 7,621,511 Class A shares through conversion of LLC interests at a zero price. Se…

FRP Holdings Director Acquires Nearly $10 Million in Stock

FRP Holdings Director Acquires Nearly $10 Million in Stock

Director John D. Baker II bought 478,468 shares of FRP Holdings, Inc. (NASDAQ: FRPH) on March 23, 2026, for $20.9 per share, a transaction valued at $9,999,981. The purchase raises Baker's total direct and indirect holdings to 3,050,243 shares amid a share price that has fallen about 27% over the past year and sits close to its 52-week low of $20.5…

EverCommerce CEO Executes $207,974 Share Sale Across Two Days

EverCommerce CEO Executes $207,974 Share Sale Across Two Days

EverCommerce Inc. CEO Eric Richard Remer sold 19,200 shares of the company on March 24 and 25, 2026, for a total of $207,974 under a Rule 10b5-1 plan. The transactions left Remer with 2,514,517 directly held shares and several larger indirect holdings. The trades follow EverCommerce's fourth-quarter 2025 report, which included a revenue beat but an…

10x Genomics CEO Disposes $288,908 in Stock Through Prearranged Plan

10x Genomics CEO Disposes $288,908 in Stock Through Prearranged Plan

10x Genomics Chief Executive Officer Serge Saxonov sold 15,000 shares of Class A Common Stock on March 23 and 24, 2026, in transactions totaling $288,908, according to a Form 4 filing. The sales were executed under a Rule 10b5-1 plan adopted November 29, 2025. The trades occurred while TXG shares have risen more than 103% over the last year and wer…

Royalty Pharma CFO Disposes of $1.58 Million in Class A Shares; Company Announces Financing and Leadership Hires

Royalty Pharma CFO Disposes of $1.58 Million in Class A Shares; Company Announces Financing and Leadership Hires

Terrance P. Coyne, Executive Vice President and CFO of Royalty Pharma plc (NASDAQ: RPRX), sold 34,791 Class A ordinary shares under a pre-arranged 10b5-1 trading plan on March 23, 2026, generating roughly $1.58 million in proceeds. The transactions, executed at a weighted average price of $45.5287 within a $45.30 to $45.94 range, included indirect …